Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03714503 · ClinicalTrials.gov registry record · NA
Head Positioning After Retina Detachment Repair
A NA study of Retina; Detachment, Rhegmatogenous, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03714503 is a NA study of Retina; Detachment, Rhegmatogenous that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03714503, a NA study of Retina; Detachment, Rhegmatogenous, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine if one day post-operative prone head positioning can be as good as seven days post-operative prone head positioning in patients with retinal detachments with inferior retinal breaks after pars that pars plana vitrectomy (PPV) using perfluoropropane (C3F8) gas as a tamponade. The investigator will conduct a single arm phase II study using a Simon's two-stage design
Conditions Studied
Interventions
- DEVICE Retina re-attachment repair using C3F8 gas tamponade
Study Locations (1)
Kansas
- University of Kansas Medical Center - Prairie Village
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-04-08 |
| Est. Completion | 2026-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03714503
The ClinicalTrials.gov registry entry for NCT03714503 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Retina; Detachment, Rhegmatogenous appearing as the primary indexed condition, and to 1 intervention - of which Retina re-attachment repair using C3F8 gas tamponade is the first listed.
NCT03714503 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT03714503 about?
NCT03714503 is a clinical study titled "Head Positioning After Retina Detachment Repair". This study aims to determine if one day post-operative prone head positioning can be as good as seven days post-operative prone head positioning in patients with retinal detachments with inferior retinal breaks after pars that pars plana vitrectomy (PPV) using perfluoropropane (C3F8) gas as a tampon...
What is the current status of trial NCT03714503?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2019-04-08. Estimated completion is 2026-10.
What conditions does trial NCT03714503 study?
This clinical trial studies the following conditions: Retina; Detachment, Rhegmatogenous.
What interventions are being tested in trial NCT03714503?
The interventions under investigation include: Retina re-attachment repair using C3F8 gas tamponade (DEVICE).
Who is sponsoring clinical trial NCT03714503?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03714503 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.